• Polybrene and the Translational Logic of p53 Reactivation

  2026-09-04

  A translational strategy for using Polybrene as a controlled gene-delivery variable when studying mutant p53 biology, including TRAP-1–mediated reactivation of p53Y220C. The article connects charge-mediated viral uptake with assay rigor, reproducibility, and the limits of extrapolating delivery performance into oncology conclusions.

• Cellular Senescence Signatures in Abdominal Aortic Aneurysm

  2026-09-04

  The reference study integrates transcriptomic analysis, cellular senescence gene sets, machine learning, and experimental validation to identify ETS1 and ITPR3 as candidate biomarkers for abdominal aortic aneurysm. Its workflow offers a practical framework for moving from discovery datasets to stage-aware validation while highlighting senescent endothelial cells as a potentially important component of aneurysm biology.

• Computational Hapten Design for Dual-Toxin Biosensing

  2026-09-03

  This 2026 study combines molecular similarity analysis, quantum chemical calculations, and antibody engineering to create a dual-target fluorescent immunochromatographic assay for amatoxins and phallotoxins in mushrooms. Its main contribution is the use of computationally guided hapten selection to improve uniform antibody recognition across chemically related toxins, enabling sensitive simultaneous screening in fresh and dried mushroom samples.

• Bobcat339 for TET Inhibition and DNA Methylation Studies

  2026-09-03

  Bobcat339 is a cytosine structure-based TET enzyme inhibitor for testing how TET1/TET2 activity connects DNA methylation regulation with gene transcription modulation. This guide translates the UHRF1–5-mC–TGM2 findings in senile osteoporosis into practical biochemical, cellular, and multi-omics workflows while emphasizing controls, dose optimization, and interpretation limits.

• Budesonide in Reliable Cell Assays

  2026-09-02

  Learn how Budesonide (SKU B1900) can be integrated into cell viability, proliferation, and airway inflammation workflows with solvent controls, exposure planning, and permeability context. The article connects product specifications with practical interpretation for asthma inflammation models and respiratory disease research.

• NADPH Oxidase ROS Drive Arterial Contraction in Rat Pups

  2026-09-02

  The reference study shows that NADPH oxidase-derived reactive oxygen species promote contraction of early postnatal rat saphenous arteries primarily through L-type voltage-gated calcium channels, rather than through Rho-kinase, PKC, or Src kinase. Its inhibitor-interaction design helps distinguish pathways that reduce contraction generally from the pathway specifically required for the ROS-sensitive contractile response.

• Vancomycin Hydrochloride as a Mechanistic Control

  2026-09-01

  Vancomycin hydrochloride is more than a Gram-positive antibacterial standard: it can define assay boundaries when antimicrobial and antibiofilm candidates are tested against difficult organisms. This article translates findings from LL-37 research into a mechanism-aware framework for susceptibility, biofilm, and resistance experiments.

• LL-37 Fragments Against MDR Acinetobacter Biofilms

  2026-09-01

  The reference study shows that human cathelicidin LL-37 and selected truncated fragments can combine rapid antibacterial activity with inhibition and disruption of multidrug-resistant Acinetobacter baumannii biofilms. Its use of MIC, time-kill, adherence, biofilm-eradication, and cytotoxicity assays provides a practical framework for evaluating peptide-based strategies against organisms that are difficult to treat.

• ARCA Cy5 EGFP mRNA (5-moUTP) Workflow

  2026-08-31

  Use ARCA Cy5 EGFP mRNA (5-moUTP) to separate cellular delivery from productive translation in microscopy and flow cytometry. Its covalent Cy5 label, EGFP reporter, ARCA cap, and 5-methoxyuridine modification support quantitative optimization of mRNA delivery systems in mammalian cells.

• Triamcinolone B1859: Practical Research Guide

  2026-08-31

  Triamcinolone B1859 provides a defined synthetic glucocorticoid agonist for controlled in vitro studies of glucocorticoid signaling, inflammation, and immunosuppression. It is intended for scientific research workflows only and should not be used for diagnostic, clinical, or therapeutic applications.

• VE-822 ATR Inhibitor Assay Workflows

  2026-08-30

  VE-822 is a potent ATR inhibitor for testing replication-stress vulnerabilities and DNA damage response inhibition in cancer models. This guide translates its use into 2D, 3D, radiation, and gemcitabine workflows, with practical controls for pancreatic ductal adenocarcinoma (PDAC) research.

• Ionomycin Calcium Salt in Translational Cancer Research

  2026-08-29

  A mechanistic and strategic guide to using Ionomycin calcium salt as a controlled calcium perturbation in cancer research, linking intracellular Ca2+ dynamics with apoptosis, Bcl-2/Bax biology, and DNA-repair-defined translational models. The article explains how to validate calcium-driven phenotypes, position the reagent alongside cisplatin and olaparib studies, and avoid overstating preclinical findings as clinical evidence.

• Pregnenolone Carbonitrile: PXR Workflows

  2026-08-28

  Pregnenolone Carbonitrile is a practical rodent PXR probe for cytochrome P450 CYP3A induction, hepatic detoxification studies, and fibrosis-related assays. This guide connects reproducible stock preparation and readouts with a newly described adenine-induced HFsnEF mouse model, while highlighting species and mechanism controls.

• Caspofungin: From Glucan Target to Assay Insight

  2026-08-28

  Caspofungin is a lipopeptide antifungal drug whose glucan-synthesis mechanism provides more than a potency readout. This article explains how delayed-treatment models, orthogonal endpoints, and resistance-aware assay design improve interpretation of Candida research.

• Bile Acid Subtypes Reveal CRC Immune Markers

  2026-08-27

  Feng et al. developed a bile acid metabolism-based molecular classification for colon adenocarcinoma and identified CLCA1, UGT2A3, and ZG16 as candidate markers of altered immunity and unfavorable disease biology. The analysis links transcriptomic subtyping with survival, immune-infiltration patterns, TIDE scores, and external expression validation, providing a framework for biomarker-focused gene expression studies.

7999 records 1/534 page Next 12345 下5页 Last page